Medical Device News Magazine

CognitiveCare Receives a Grant of Nearly $1 Million to Advance Maternal and Fetal Health

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

CognitiveCare a Healthcare AI startup and pioneer in maternal and infant health, today announced it has received a $965,871 grant from the Bill & Melinda Gates Foundation to provide antenatal risk stratification AI support for the ARC’s pregnancy surveillance efforts.

According to the World Health Organization (WHO), global maternal mortality is an unacceptably high 810 deaths per day, primarily from preventable or treatable causes. Further, 10–15% of all infants born are preterm and are at increased risk of morbidity and mortality.

As part of this grant, CognitiveCare will detect and quantify propensity for critical adverse outcomes during antepartum, intrapartum, and postpartum stages, by leveraging CognitiveCare’s Maternal Infant Health Insights & Cognitive intelligence ”MIHIC” solution. MIHIC incorporates granular insights and patterns that interplay with clinical and social determinants of health to help detect and quantify risks at individual and population levels. CognitiveCare will first validate its models with local data and will then integrate MIHIC into both the Kenya PRiSMA (western Kenya) and the Aga Khan University & VITAL Pakistan ARC sites’ existing production environments. A segment of this grant is dedicated to train the ARC sites to use MIHIC, ensuring sustainable impact.

“With the foundation’s grant support, our aim is to support caregivers in understanding propensity for risk early enough to help reduce maternal and infant morbidity and mortality,” said Dr. Suresh Attili, Co-Founder and Chief Medical Officer, CognitiveCare. “Decisions on patient care rest with physicians; however, risk scores generated by MIHIC support triaging patients early. The models will further provide explainable AI functionality to help caregivers understand the ‘why’ behind each MIHIC ScoreTM.”

“Given that 94% of all maternal deaths occur in low- and lower-middle-income countries, CognitiveCare is committed to ensuring that low resource settings have access to MIHIC,” said Sheena Gill, President, Americas for CognitiveCare. “With this grant, we take another important step toward our vision to eradicate maternal and infant mortality globally.”

CognitiveCare is working at the forefront of science to build the world’s first comprehensive health risk quantification solution that integrates AI, advanced math, and stats at the intersection of medicine, biology, genomics and social determinants. CognitiveCare’s MIHIC Score™ platform assesses propensity for risk of maternal, fetal and infant health risks categorized as antepartum, intrapartum and postpartum risk scores early in the pregnancy cycle to empower proactive care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”